Semaglutide - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
OZEMPIC 0.25 mg/0.5mg semaglutide (rys) 0.68 mg/mL solution for injection in 3mL pre-filled pen
AUST R: 446290
Active ingredients:
Semaglutide

Dosage form:
Injection, solution

Sponsor:
Novo Nordisk Pharmaceuticals Pty Ltd

Phone:
1800668626

From
01 Jun 2025
to
18 Jul 2025

Shortage status:
Resolved

Availability:
Available

Reason:
Unexpected increase in consumer demand

Management action:
A TGA web statement is available at: https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/ozempic-semaglutide-supply-information
OZEMPIC 1 mg semaglutide (rys) 1.34 mg/mL solution for injection pre-filled pen
AUST R: 315107
Active ingredients:
Semaglutide

Dosage form:
Injection, solution

Sponsor:
Novo Nordisk Pharmaceuticals Pty Ltd

Phone:
1800668626

From
15 Apr 2022
to
18 Jul 2025

Shortage status:
Resolved

Availability:
Available

Reason:
Unexpected increase in consumer demand

Management action:
An updated TGA web statement is available at: https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/ozempic-semaglutide-supply-information
OZEMPIC 0.25/0.5 mg semaglutide (rys) 1.34 mg/mL solution for injection pre-filled pen
AUST R: 308324
Active ingredients:
Semaglutide

Dosage form:
Injection, solution

Sponsor:
Novo Nordisk Pharmaceuticals Pty Ltd

Phone:
1800668626

Deletion from market:
01 Dec 2025

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
This product will be replaced by ARTG 446290 OZEMPIC 0.25 mg/0.5mg semaglutide (rys) 0.68 mg/mL solution for injection in 3mL pre-filled pen. More information about this supply change is available from https://www.tga.gov.au/safety/shortages/medicine-shortage-alerts/new-presentation-ozempic-semaglutide-025-mg05-mg-pre-filled-pens. An updated TGA web statement about Ozempic supply is available at: https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/ozempic-semaglutide-supply-information